Literature DB >> 17448333

The role of antileukotriene drugs in management of rhinitis and rhinosinusitis.

Mitchell H Grayson1, Phillip E Korenblat.   

Abstract

Antileukotriene drugs have been studied for more than 15 years. In this review we examine the role of leukotrienes in rhinitis and rhinosinusitis, and explore the clinical literature supporting the use of anti-leukotriene agents in these diseases. Although these medications clearly are efficacious in rhinitis, it is unclear where in the armamentarium they should be used. The evidence for use in sinusitis has not been well studied except in sinusitis-associated aspirin-exacerbated respiratory disease. In this circumstance there is information that allows use of antileukotriene agents to be considered efficacious. We provide our rationale for use and await future clinical studies to answer this important question.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448333     DOI: 10.1007/s11882-007-0074-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  58 in total

1.  Rhinosinusitis: developing guidance for clinical trials.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Allen D Adinoff; Claus Bachert; Larry Borish; Vernon M Chinchilli; Melvyn R Danzig; Berrylin J Ferguson; Wytske J Fokkens; Stephen G Jenkins; Valerie J Lund; Mahmood F Mafee; Robert M Naclerio; Ruby Pawankar; Jens U Ponikau; Mark S Schubert; Raymond G Slavin; Michael G Stewart; Alkis Togias; Ellen R Wald; Birgit Winther
Journal:  J Allergy Clin Immunol       Date:  2006-11       Impact factor: 10.793

2.  Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor.

Authors:  M Sjöström; P J Jakobsson; M Heimburger; J Palmblad; J Z Haeggström
Journal:  Eur J Biochem       Date:  2001-05

3.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.

Authors:  S E Wenzel; S J Szefler; D Y Leung; S I Sloan; M D Rex; R J Martin
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

4.  Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.

Authors:  B Dahlén; E Nizankowska; A Szczeklik; O Zetterström; G Bochenek; M Kumlin; L Mastalerz; G Pinis; L J Swanson; T I Boodhoo; S Wright; L M Dubé; S E Dahlén
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

5.  The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans.

Authors:  Sabina A Islam; Seddon Y Thomas; Christoph Hess; Benjamin D Medoff; Terry K Means; Christian Brander; Craig M Lilly; Andrew M Tager; Andrew D Luster
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

6.  Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.

Authors:  H M Sarau; R S Ames; J Chambers; C Ellis; N Elshourbagy; J J Foley; D B Schmidt; R M Muccitelli; O Jenkins; P R Murdock; N C Herrity; W Halsey; G Sathe; A I Muir; P Nuthulaganti; G M Dytko; P T Buckley; S Wilson; D J Bergsma; D W Hay
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

7.  Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis.

Authors:  Chris Corrigan; Kirsty Mallett; Sun Ying; David Roberts; Abhi Parikh; Glenis Scadding; Tak Lee
Journal:  J Allergy Clin Immunol       Date:  2005-02       Impact factor: 10.793

8.  Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.

Authors:  Paul H Ratner; William C Howland; Raiqua Arastu; Edward E Philpot; Kristofer C Klein; Charlotte A Baidoo; Melissa A Faris; Kathleen A Rickard
Journal:  Ann Allergy Asthma Immunol       Date:  2003-05       Impact factor: 6.347

Review 9.  The emerging role of leukotriene modifiers in allergic rhinitis.

Authors:  Mitchell H Grayson; Phillip E Korenblat
Journal:  Am J Respir Med       Date:  2003

10.  Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.

Authors:  M Kurowski; P Kuna; P Górski
Journal:  Allergy       Date:  2004-03       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.